Home > Press > Proofreading and error-correction in nanomaterials inspired by nature
The new proofreading and error-removal process is based on catalytic DNA and represents a paradigm shift in nanoscale science and engineering
Proofreading and error-correction in nanomaterials inspired by nature
Champaign, IL | October 18, 2005
Mimicking nature, a procedure developed by researchers at the University of Illinois at Urbana-Champaign can find and correct defects in self-assembled nanomaterials. The new proofreading and error-removal process is based on catalytic DNA and represents a paradigm shift in nanoscale science and engineering.
Despite much progress made in the self-assembly of nanomaterials, defects that occur during the assembly process still present major obstacles for applications such as molecular electronics and photonics. Efforts to overcome this problem have focused on optimizing the assembly process to minimize errors, and designing devices that can tolerate errors.
"Instead of trying to avoid defects or work around them, it makes more sense to accept defects as part of the process and then correct them during and after the assembly process," said Yi Lu, a chemistry professor at Illinois and a researcher at the Beckman Institute for Advanced Science and Technology. "This procedure is analogous to how nature deals with defects, and can be applied to the assembly of nanomaterials using biomolecules or biomimetic compounds."
In protein synthesis, nature ensures accuracy by utilizing a proofreading unit that detects and corrects errors in translation, often through hydrolysis of incorrect amino acid building blocks. In a similar fashion, Lu and graduate students Juewen Liu and Daryl Wernette utilized catalytic DNA to locate and remove errors in a DNA-templated gold nanoparticle assembly process. The researchers describe the procedure in a paper accepted for publication in the journal Angewandte Chemie International Edition, and posted on its Web site.
Catalytic DNA contains a substrate strand and an enzyme strand. In the presence of certain ions, the substrate is cleaved by the enzyme into two pieces of unequal length. The cleaved fragment with the shorter binding arm can be easily released. This catalytic DNA serves as a template for assembly of nanoparticles.
There are three kinds of nanoparticles encoded by different DNA in the system: two are defined as "correct" particles and one is defined as a "wrong" particle. Besides the difference in coding DNA, the nanoparticles can also be different in other aspects, such as size.
"To allow the catalytic DNA substrate to be a template for nanoparticle assembly, the substrate strand must be complementary to the DNA attached to the nanoparticles," Lu said. "A defect can occur in a DNA-templated gold nanoparticle assembly when the wrong particle is incorporated into the structure."
When a particle of the correct size is encountered, binding of the longer arm of the enzyme to the DNA template is permitted, while binding of the shorter arm to the DNA template is inhibited. "The active structure of the catalytic DNA cannot form," Lu said. "As a result, the template is not cleaved and the particle is incorporated into the assembly."
When a particle of the wrong size is mistakenly incorporated into the assembly, the enzyme can bind both its arms to the substrate template and form an active structure to cleave the substrate and remove the particle.
By showing that defects - the wrong size particles, in this case - can be identified and removed, the researchers demonstrated that proofreading and error-correction can take place during and after the assembly of nanoparticles.
"This was a small, but definite, step in the right direction," Lu said. "The error-correction procedure can be expanded to include many other biomolecules and biomimetic compounds for controlling the assembly of nanoparticles of defined particle sizes, shapes or compositions; as well as other nanomaterials, such as nanotubes and nanowires."
The researchers have applied for a patent. The work was funded by the U.S. Department of Defense and the National Science Foundation.
Editor's note: To reach Yi Lu, call 217-333-2619; email@example.com.
James E. Kloeppel
Physical Sciences Editor
Copyright © University of Illinois at Urbana-Champaign
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Virus structure inspires novel understanding of onion-like carbon nanoparticles April 10th, 2014
Local girl does good March 22nd, 2014
Surface Characteristics Influence Cellular Growth on Semiconductor Material March 12th, 2014
The "Tipping Point" February 12th, 2014
Roomy cages built from DNA: Self-assembling cages are the largest standalone 3-D DNA structures yet, and could one day deliver drugs, or house tiny bioreactors or photonic devices March 13th, 2014
Cypress’s TrueTouch® Touchscreen Controllers Compatible with Cima NanoTech’s SANTE® Silver Nanoparticle-Based Touch Sensors: Supporting Designs for Advanced Touch Applications March 5th, 2014
Coupled carbon and peptide nanotubes achieved for the first time: twins nanotubes March 1st, 2014
A potentially revolutionnary material: Scientists produce a novel form of artificial graphene February 15th, 2014
Thinnest feasible membrane produced April 17th, 2014
INSCX™ exchange to present Exchange trade reporting mechanism for engineered nanomaterials (NMs) to UK regulation agencies, insurers and upstream/downstream users April 17th, 2014
Engineers develop new materials for hydrogen storage April 15th, 2014
Industrial Nanotech, Inc. Lands First Major Order from Pemex, Mexico’s State-Owned Oil and Gas Company April 14th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Nanoparticles cause cancer cells to self-destruct April 3rd, 2014
A*STAR's Simtech collaboration agreements to accelerate the growth and development of the microfluidics industry April 1st, 2014
Dolomite releases novel droplet-on-demand sequencing and droplet generation microfluidic system April 1st, 2014